Seeking Alpha

AMRS

Amyris Biotechnologies

5/27/2012, 2:47 PM ET

Business Intelligence
Transcripts
Events
Key Developments

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

220 people get AMRS articles and Market Currents by email alert.

Get email alerts on AMRS »

AMRS Market Currents more »

May 8 Amyris (AMRS): Q1 EPS of -$1.88 may not be comparable to consensus of -$0.76. Revenue of $29.5M (-21% Y/Y). Shares -12.6% AH. (PR)
Comment!
[Earnings, On the Move]

AMRS in Focus more »

Amyris Finds Scaling Up More Difficult Than Expected

The Burrill Report • Sun, Feb 19 • 8 Comments
Amyris Moves Into Commercial Production Amid Biofuel Renaissance

Greentech Media • Sun, May 1, 2011 • 2 Comments
Amyris Completes IPO With Impressive Partnerships Pipeline: Biotech's Latest Deals

The Burrill Report • Sun, Oct 3, 2010 • Comment!
Amyris Biotech Prices IPO Below Range

Mohit Manghnani • Tue, Sep 28, 2010 • Comment!
Amyris Biotechnologies: Another Biofuel Company Seeks Public Funds, Let the Criticism Begin

Greentech Media • Tue, Sep 14, 2010 • 1 Comment

AMRS Related Articles more »

Solazyme: An Undervalued Investment With A Hidden Identity

Kevin Quon • Thu, May 24 • 4 Comments
Top Insider Trades On May 22: Facebook IPO Sales

InsiderInsights • Wed, May 23 • 2 Comments
Another Blow To The Biofuel Industry

Kevin Quon • Mon, May 14 • 7 Comments
Top 2 High Growth Alternative Energy Stocks Trading At Lows Being Bought By Mega Funds

Ganaxi Small Cap Movers • Thu, May 10 • 8 Comments
12 High-Growth Small Caps Under $5 Being Bought Up By Hedge Funds

Kapitall • Fri, Apr 27 • 3 Comments
Noteworthy Institutional 5% Ownership Filings Last Week

Ganaxi Small Cap Movers • Sun, Apr 15 • 2 Comments
9 High-Growth Biotech Stocks Being Bought Up By Hedge Funds

Kapitall • Wed, Apr 11 • Comment!
Fulcrum Holds Advantage Over A Host Of Competitors

Kevin Quon • Tue, Apr 10 • 4 Comments
7 Ways To Play The Advanced Biofuel Revolution

Kevin Quon • Tue, Apr 3 • 10 Comments
IPO Preview: Enerkem

IPOdesktop • Mon, Apr 2 • 1 Comment

AMRS News more »

Movers & Shakers: Tuesday’s biggest gaining and declining stocks

at MarketWatch.com (Feb 28, 2012)
Movers & Shakers: Monday’s biggest gaining, declining stocks

at MarketWatch.com (Feb 27, 2012)
Renewable fuel scales up, hits bumps

at MarketWatch.com (Feb 17, 2012)
Movers & Shakers: Friday’s biggest gaining and declining stocks

at MarketWatch.com (Feb 10, 2012)
VC John Doerr fired up on energy research

at MarketWatch.com (Sep 28, 2011)

AMRS Press Releases and Filings more »

Amyris Reports First Quarter 2012 Financial Results

GlobeNewswire (May 8, 2012)
Amyris Realigns Senior Leadership to Support Growth Strategy

GlobeNewswire (May 2, 2012)
Amyris to Announce 2012 First Quarter Financial Results on Tuesday, May 8

GlobeNewswire (Apr 19, 2012)
Amyris Names Steven R. Mills as New Chief Financial Officer

Business Wire (Mar 28, 2012)

AMRS Latest Transcript more »

Currently, there are no transcripts for AMRS.

AMRS Cramer more »

Cramer's Mad Money - Health Is Wealth - Hain Celestial and Lululemon (2/7/11)

Tue, Feb 8, 2011
Cramer's Mad Money - A Mad Week of IPOs (9/27/10)

Tue, Sep 28, 2010

AMRS Instablog posts more »

11 Next-Generation Commodity Names

Fri, Oct 7, 2011 • Kate Stalter • Comment!
Amyris: an Unattractive Risk Reward Profile

Fri, Apr 29, 2011 • BuyGreenSellHigh • Comment!
Amyris Tops List of 50 Hottest Bioenergy Companies

Tue, Dec 7, 2010 • SustainableBusiness • Comment!
US Cleantech Venture Capital Falls 55% in 3Q

Tue, Nov 2, 2010 • SustainableBusiness • Comment!
Cleantech Venture Investments Down in 3Q

Wed, Oct 6, 2010 • SustainableBusiness • Comment!

Write a post on AMRS

AMRS StockTalks

AMRS vs. ETF Alternatives

Company Description

Currently, there's no company description for AMRS.

Sector: Healthcare

Industry: Biotechnology

Country: United States